Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Can. 2011;33(10):995-1004.
(280.12 KB)
. 
Are long-term health risks of pre-eclampsia and intrauterine growth restriction really the same?. BJOG. 2015;122(13):1824.
(33.63 KB)
. 
Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis-fundus height. Ultrasound Obstet Gynecol. 2015;46(2):182-90.
(349.22 KB)
. 
Extending the scope of pooled analyses of individual patient biomarker data from heterogeneous laboratory platforms and cohorts using merging algorithms. Pregnancy Hypertens. 2016;6(1):53-9.
(821.08 KB)
. 
PIERS proteinuria: relationship with adverse maternal and perinatal outcome. J Obstet Gynaecol Can. 2011;33(6):588-597.
(292.91 KB)
. 
Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction. Placenta. 2016;42:1-8.
(475.29 KB)
. 
Redefining preeclampsia using placenta-derived biomarkers. Hypertension. 2013;61(5):932-42.
(529.57 KB)
. 